We deliver insight and guidance for strategic decision-making in the Life Sciences. As representatives of the pharma industry, we have unique expertise in and knowledge of the Nordic public healthcare systems. With a multi-dimensional view of healthcare data, we carry out analyses and outline the roads ahead, enabling you to decide on the best course of action for your business.
New collaboration with Medaffcon
Enhancing Nordic RWE studies
The combined expertise of DLIMI and Medaffcon represent the fields of RWE, medical and data sciences, and health economics and with this collaboration we can conduct even better real world studies in order to strengthen patient centric access to medicine.
What we do
MULTI-DIMENSIONAL DATA VIEW
DLIMI are your analysts and data advisors. As representatives of the pharma industry, we have unique expertise in both Life Science and the Nordic public healthcare systems.
To use data to examine (something) methodically and in detail.
Typically in order to interpret it and determine an appropriate course of action.
a vision of
It is fundamental for DLIMI that insights generated in our research and projects become part of the open, shared body of knowledge on which the pharmaceutical and healthcare sectors advance
Get instant insights
Access to the whole Nordic region via Nordic collaboration on exchange of data
One of the most reliable pharma product statistics in the world with 20+ data sources
Extensive, reliable datasets with daily updates for 60,000 product lines
Medicines directed at the Nordic hospital sector face a range of obstacles enroute to the marketplace. With the right approach, they can be overcomed and conquered.
Get access to detailed market insights that help the dissemination, understanding and use of your medicine as a trusted treatment option.
Detailed market insights, daily reports and analyses supporting your particular pharmacy focus are tools to your continued success.
SIGN UP FOR OUR NEWSLETTER
Get the latest news, instant insights, cases, whitepapers and stay up to date.
We promise only to send relevant and exiting news.